CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-28 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,176 | $237.44 | $279K | 60,926 |
| 2026-01-28 | Sheena Jonathan Director | Sale 10b5-1 | −191 | $237.66 | $45K | 263,596 |
| 2026-01-27 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −784 | $240.53 | $189K | 176,468 |
| 2026-01-27 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,013 | $240.53 | $244K | 143,686 |
| 2026-01-27 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −886 | $240.53 | $213K | 226,147 |
| 2026-01-27 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −2,322 | $240.53 | $559K | 216,828 |
| 2026-01-27 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −784 | $240.53 | $189K | 63,339 |
| 2026-01-27 | Sheena Jonathan Director | Sale 10b5-1 | −291 | $240.53 | $70K | 263,787 |
| 2026-01-23 | Sheena Jonathan Director | Sale 10b5-1 | −160 | $242.31 | $39K | 22,372 |
| 2026-01-23 | Sheena Jonathan Director | Sale 10b5-1 | −185 | $243.49 | $45K | 22,187 |
| 2026-01-23 | Sheena Jonathan Director | Sale 10b5-1 | −355 | $244.78 | $87K | 21,832 |
| 2026-01-23 | Sheena Jonathan Director | Sale 10b5-1 | −50 | $245.62 | $12K | 21,782 |
| 2026-01-23 | Sheena Jonathan Director | Sale 10b5-1 | −200 | $242.23 | $48K | 22,332 |
| 2026-01-23 | Sheena Jonathan Director | Sale 10b5-1 | −160 | $243.59 | $39K | 22,172 |
| 2026-01-23 | Sheena Jonathan Director | Sale 10b5-1 | −390 | $244.87 | $96K | 21,782 |
| 2026-01-21 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −339 | $235.00 | $80K | 177,252 |
| 2026-01-21 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −293 | $235.00 | $69K | 144,699 |
| 2026-01-21 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −438 | $235.00 | $103K | 227,033 |
| 2026-01-21 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −1,590 | $235.00 | $374K | 219,150 |
| 2026-01-21 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −602 | $235.00 | $141K | 100,696 |
Page 28 of 39 · 767 trades